WELCH CAPITAL PARTNERS LLC/NY - Q4 2020 holdings

$360 Million is the total value of WELCH CAPITAL PARTNERS LLC/NY's 23 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was - .

 Value Shares↓ Weighting
RSP NewINVESCO EXCHANGE TRADED FD Ts&p500 eql wgt$10,409,00081,610
+100.0%
2.89%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-02-10
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SPIDERS INDEX42Q3 202352.7%
Alphabet Inc-Cl C32Q3 20236.3%
BLACKSTONE GROUP INC32Q3 20234.4%
HUMANA INC29Q3 20235.9%
CVS HEALTH CORP28Q4 20225.0%
Paypal Inc27Q3 20234.4%
BRIGHT HORIZONS FAMILY SOLUTIONS INC26Q3 20194.5%
Proctor & Gamble26Q3 20190.9%
UNITED TECHNOLOGIES26Q3 20190.2%
VANGUARD WORLD FDS25Q3 202341.4%

View WELCH CAPITAL PARTNERS LLC/NY's complete holdings history.

Latest significant ownerships (13-D/G)
WELCH CAPITAL PARTNERS LLC/NY Q4 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
HEALTHTRONICS SURGICAL SERVICES INCFebruary 12, 2004911.0%
HMS HOLDINGS CORPFebruary 12, 2004911.0%
REGENERATION TECHNOLOGIES INCFebruary 12, 2004911.0%
SONUS PHARMACEUTICALS INCFebruary 12, 2004911.0%
DRAXIS HEALTH INC /CN/March 07, 2003911.0%
PRAECIS PHARMACEUTICALS INCMarch 04, 2003911.0%

View WELCH CAPITAL PARTNERS LLC/NY's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-05
13F-HR2023-11-06
13F-HR2023-08-08
13F-HR2023-05-11
13F-HR2023-02-02
13F-HR2022-11-08
13F-HR2022-08-17
13F-HR2022-05-13
13F-HR2022-02-08
13F-HR2021-11-04

View WELCH CAPITAL PARTNERS LLC/NY's complete filings history.

Compare quarters

Export WELCH CAPITAL PARTNERS LLC/NY's holdings